American Society of Clinical Oncology

SHERPA: White

People

  1. Grisham
    Grisham
  2. Tew
    Tew
  3. O'Cearbhaill
    O'Cearbhaill
  4. Aghajanian
    Aghajanian
  5. Konner
    Konner
  6. Makker
    Makker
  7. Iasonos
    Iasonos
  8. Hensley
    Hensley
  9. Zhou
    Zhou
  10. Kyi
    Kyi

Groups

  1. Department of Medicine (11)
  2. GDMT, Medicine (11)
  3. Gynecologic Medicine Service (11)
  4. Gynecology Disease Management Team (11)
  5. Hematologic Malignancies, Division of (11)
  6. Solid Tumor Oncology Division (11)
  7. Biostatistics Service (7)
  8. Epidemiology and Biostatistics (7)
  9. Early Drug Development Service (6)
  10. Human Oncology and Pathogenesis Program (6)
Search Within
  1. "William Tew"
  2. "Rachel Grisham"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (1)
Groups
  1. Department of Medicine (11)
  2. GDMT, Medicine (11)
  3. Gynecologic Medicine Service (11)
  4. Gynecology Disease Management Team (11)
  5. Hematologic Malignancies, Division of (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Rachel Grisham (11)
  2. William Tew (11)
  3. Roisin O'Cearbhaill (10)
  4. Carol Aghajanian (9)
  5. Jason Konner (9)
  6. Vicky Makker (9)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (3)
  4. 2019 (1)
  5. 2018 (1)
  6. 2017 (3)

More Years

Publications
  1. Journal of Clinical Oncology (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR plus ) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Iasonos, A.; Girshman, J.; Cadoo, K. A.; Kyi, C.; Makker, V.; Cohen, S. M.; O'Cearbhaill, R. E.; Sabbatini, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A randomized phase II trial of secondary cytoreductive surgery (SCS) plus /- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)
    Meeting Abstract

    Zivanovic, O.; Chi, D.; Zhou, Q.; Iasonos, A.; Makker, V.; Grisham, R. N.; Konner, J. A.; Diaz, J. P.; Brown, A. K.; Langstraat, C. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Risk of venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer
    Meeting Abstract

    Basaran, D.; Suhner, J.; Sassine, D.; Boerner, T.; Liu, Y. L.; Grisham, R. N.; Tew, W. P.; Gardner, G. J.; Zivanovic, O.; Sonoda, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma
    Meeting Abstract

    Konner, J. A.; Boucicaut, N. N.; O'Cearbhaill, R. E.; Zamarin, D.; Makker, V.; Sabbatini, P.; Tew, W. P.; Cadoo, K. A.; Grisham, R. N.; Aghajanian, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save